Farmacogenómica del Cáncer ; Pharmacogenomic of cancer
Gedelcan
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublications in collaboration with researchers from Hospital Clínico Universitario Lozano Blesa (11)
2024
-
[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245
2023
-
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas
2022
-
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity
Biomedicines, Vol. 10, Núm. 3
2021
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Institutional factors associated with adherence to enhanced recovery protocols for colorectal surgery: Secondary analysis of a multicenter study
Journal of Clinical Anesthesia, Vol. 74
-
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score
British Journal of Surgery, Vol. 19, Núm. 4
2020
-
Neuromuscular blockade management and postoperative outcomes in enhanced recovery colorectal surgery: Secondary analysis of POWER trial
Minerva Anestesiologica, Vol. 87, Núm. 1, pp. 13-25
2019
-
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
Therapeutic Advances in Gastroenterology, Vol. 12
2016
2007
-
Thiopurine methyltransferase activity in Spain: A study of 14,545 patients
Digestive Diseases and Sciences, Vol. 52, Núm. 5, pp. 1262-1269
2005
-
Actividad de la tiopurina metiltransferasa en la enfermedad inflamatoria intestinal. Un estudio en 7.046 pacientes españoles
Medicina Clinica, Vol. 125, Núm. 8, pp. 281-285